Chapter 1. Research Scope
1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
1.4.1. Market size breakdown, by type
1.4.2. Market size breakdown, by application
1.4.3. Market size breakdown, by end user
1.4.4. Market size breakdown, by region
1.4.5. Market size breakdown, by country
1.5. Market Data Reporting Unit
1.5.1. Value
1.6. Key Stakeholders
Chapter 2. Research Methodology
2.1. Secondary Research
2.1.1. Paid
2.1.2. Unpaid
2.1.3. P&S Intelligence database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Voice of Industry Experts/KOLs
Chapter 5. Market Indicators
Chapter 6. Industry Outlook
6.1. Market Dynamics
6.1.1. Trends
6.1.2. Drivers
6.1.3. Restraints/challenges
6.1.4. Impact analysis of drivers/restraints
6.2. Impact of COVID-19
6.3. Porter’s Five Forces Analysis
6.3.1. Bargaining power of buyers
6.3.2. Bargaining power of suppliers
6.3.3. Threat of new entrants
6.3.4. Intensity of rivalry
6.3.5. Threat of substitutes
Chapter 7. Global Market
7.1. Overview
7.2. Market Revenue, by Type (2017–2030)
7.3. Market Revenue, by Application (2017–2030)
7.4. Market Revenue, by End user (2017–2030)
7.5. Market Revenue, by Region (2017–2030)
Chapter 8. North America Market
8.1. Overview
8.2. Market Revenue, by Type (2017–2030)
8.3. Market Revenue, by Application (2017–2030)
8.4. Market Revenue, by End user (2017–2030)
8.5. Market Revenue, by Country (2017–2030)
Chapter 9. Europe Market
9.1. Overview
9.2. Market Revenue, by Type (2017–2030)
9.3. Market Revenue, by Application (2017–2030)
9.4. Market Revenue, by End user (2017–2030)
9.5. Market Revenue, by Country (2017–2030)
Chapter 10. APAC Market
10.1. Overview
10.2. Market Revenue, by Type (2017–2030)
10.3. Market Revenue, by Application (2017–2030)
10.4. Market Revenue, by End user (2017–2030)
10.5. Market Revenue, by Country (2017–2030)
Chapter 11. LATAM Market
11.1. Overview
11.2. Market Revenue, by Type (2017–2030)
11.3. Market Revenue, by Application (2017–2030)
11.4. Market Revenue, by End user (2017–2030)
11.5. Market Revenue, by Country (2017–2030)
Chapter 12. MEA Market
12.1. Overview
12.2. Market Revenue, by Type (2017–2030)
12.3. Market Revenue, by Application (2017–2030)
12.4. Market Revenue, by End user (2017–2030)
12.5. Market Revenue, by Country (2017–2030)
Chapter 13. U.S. Market
13.1. Overview
13.2. Market Revenue, by Type (2017–2030)
13.3. Market Revenue, by Application (2017–2030)
13.4. Market Revenue, by End user (2017–2030)
Chapter 14. Canada Market
14.1. Overview
14.2. Market Revenue, by Type (2017–2030)
14.3. Market Revenue, by Application (2017–2030)
14.4. Market Revenue, by End user (2017–2030)
Chapter 15. Germany Market
15.1. Overview
15.2. Market Revenue, by Type (2017–2030)
15.3. Market Revenue, by Application (2017–2030)
15.4. Market Revenue, by End user (2017–2030)
Chapter 16. France Market
16.1. Overview
16.2. Market Revenue, by Type (2017–2030)
16.3. Market Revenue, by Application (2017–2030)
16.4. Market Revenue, by End user (2017–2030)
Chapter 17. U.K. Market
17.1. Overview
17.2. Market Revenue, by Type (2017–2030)
17.3. Market Revenue, by Application (2017–2030)
17.4. Market Revenue, by End user (2017–2030)
Chapter 18. Italy Market
18.1. Overview
18.2. Market Revenue, by Type (2017–2030)
18.3. Market Revenue, by Application (2017–2030)
18.4. Market Revenue, by End user (2017–2030)
Chapter 19. Spain Market
19.1. Overview
19.2. Market Revenue, by Type (2017–2030)
19.3. Market Revenue, by Application (2017–2030)
19.4. Market Revenue, by End user (2017–2030)
Chapter 20. Japan Market
20.1. Overview
20.2. Market Revenue, by Type (2017–2030)
20.3. Market Revenue, by Application (2017–2030)
20.4. Market Revenue, by End user (2017–2030)
Chapter 21. China Market
21.1. Overview
21.2. Market Revenue, by Type (2017–2030)
21.3. Market Revenue, by Application (2017–2030)
21.4. Market Revenue, by End user (2017–2030)
Chapter 22. India Market
22.1. Overview
22.2. Market Revenue, by Type (2017–2030)
22.3. Market Revenue, by Application (2017–2030)
22.4. Market Revenue, by End user (2017–2030)
Chapter 23. Australia Market
23.1. Overview
23.2. Market Revenue, by Type (2017–2030)
23.3. Market Revenue, by Application (2017–2030)
23.4. Market Revenue, by End user (2017–2030)
Chapter 24. South Korea Market
24.1. Overview
24.2. Market Revenue, by Type (2017–2030)
24.3. Market Revenue, by Application (2017–2030)
24.4. Market Revenue, by End user (2017–2030)
Chapter 25. Brazil Market
25.1. Overview
25.2. Market Revenue, by Type (2017–2030)
25.3. Market Revenue, by Application (2017–2030)
25.4. Market Revenue, by End user (2017–2030)
Chapter 26. Mexico Market
26.1. Overview
26.2. Market Revenue, by Type (2017–2030)
26.3. Market Revenue, by Application (2017–2030)
26.4. Market Revenue, by End user (2017–2030)
Chapter 27. Saudi Arabia Market
27.1. Overview
27.2. Market Revenue, by Type (2017–2030)
27.3. Market Revenue, by Application (2017–2030)
27.4. Market Revenue, by End user (2017–2030)
Chapter 28. South Africa Market
28.1. Overview
28.2. Market Revenue, by Type (2017–2030)
28.3. Market Revenue, by Application (2017–2030)
28.4. Market Revenue, by End user (2017–2030)
Chapter 29. U.A.E. Market
29.1. Overview
29.2. Market Revenue, by Type (2017–2030)
29.3. Market Revenue, by Application (2017–2030)
29.4. Market Revenue, by End user (2017–2030)
Chapter 30. Competitive Landscape
30.1. List of Market Players and their Offerings
30.2. Competitive Benchmarking of Key Players
30.3. Product Benchmarking of Key Players
30.4. Recent Strategic Developments
Chapter 31. Company Profiles
31.1. MIMEDX Group, Inc
31.1.1. Business overview
31.1.2. Product and service offerings
31.1.3. Key financial summary
31.2. VIVEX Biologics, Inc
31.2.1. Business overview
31.2.2. Product and service offerings
31.3. Organogenesis Holdings Inc
31.3.1. Business overview
31.3.2. Product and service offerings
31.3.3. Key financial summary
31.4. Integra Lifesciences Holdings Corporation
31.4.1. Business overview
31.4.2. Product and service offerings
31.4.3. Key financial summary
31.5. Stryker Corporation
31.5.1. Business overview
31.5.2. Product and service offerings
31.5.3. Key financial summary
31.6. Applied Biologics
31.6.1. Business overview
31.6.2. Product and service offerings
31.7. Celularity Inc
31.7.1. Business overview
31.7.2. Product and service offerings
31.7.3. Key financial summary
31.8. Skye Biologics Holdings, LLC
31.8.1. Business overview
31.8.2. Product and service offerings
31.9. Lucina BioSciences, LLC
31.9.1. Business overview
31.9.2. Product and service offerings
31.10. Next Biosciences
31.10.1. Business overview
31.10.2. Product and service offerings
31.11. TissueTech, Inc
31.11.1. Business overview
31.11.2. Product and service offerings
31.11.3. Key financial summary
31.12. Corza Ophthalmology
31.12.1. Business overview
31.12.2. Product and service offerings
31.13. Merakris Therapeutics, Inc
31.13.1. Business overview
31.13.2. Product and service offerings
31.14. Ventris Medical, LLC
31.14.1. Business overview
31.14.2. Product and service offerings
31.15. Tides Medical
31.15.1. Business overview
31.15.2. Product and service offerings
Chapter 32. Appendix
32.1. Abbreviations
32.2. Sources and References
32.3. Related Reports
| ※参考情報 羊膜製品とは、羊膜から得られる生物由来の製品で、主に医療や再生医療の分野で使用されています。羊膜は、羊の胎児を包み込む膜であり、豊富な成長因子や細胞外マトリックス成分を含んでいます。これにより、羊膜製品は組織修復や再生を促進する特性を持ち、多岐にわたる用途があります。 羊膜製品の種類は、主に羊膜の加工方法によって分類されます。最も一般的な形態は、ウェイファー状の羊膜です。これは、羊膜を薄くスライスし、そのまま貼付することで使用することができます。これにより、直接的な創傷治癒や皮膚再生を促進します。また、羊膜を乾燥させた形状の製品もあり、これは糊付けや注入が可能です。 他にも、液体状の羊膜製品も存在します。これは、羊膜から抽出した成分を濃縮したもので、点眼剤や関節内注射として使用されることがあります。これらの製品は、関節炎や眼科疾患に対する治療として注目されています。 羊膜製品の用途は多岐にわたり、特に外科手術や創傷治癒の領域で重要な役割を果たしています。手術後の瘢痕形成を抑制したり、組織移植における拒絶反応を軽減するために使用されます。さらに、糖尿病性潰瘍や深部静脈血栓症による皮下組織の損傷修復にも効果を示すことが報告されています。 羊膜製品はまた、眼科の領域でも応用されています。例えば、角膜移植後の拒否反応を抑えるために羊膜が用いられ、視力回復を助けることが期待されています。これらの利用方法は、従来の治療法に比べて効果的であり、患者の回復を早めることができるとされています。 関連技術としては、羊膜製品の製造技術の進歩が挙げられます。近年では、動物由来の材料を用いた再生医療が増加しており、その中で羊膜を利用した製品の需要が高まっています。羊膜の収集と加工には厳格な品質管理が求められ、医療機器としての安全性を確保するための各種試験が行われます。 さらに、バイオロジカルな特性を強化するための研究も進んでいます。例えば、羊膜の成分に新たな成長因子や細胞を組み込むことで、創傷治癒機能を向上させる手法が開発されています。これにより、羊膜製品の効果がさらに高まる可能性があります。 羊膜製品は、今後も再生医療や外科治療において重要な資源として位置づけられるでしょう。新たな技術や製品の開発が進む中で、羊膜製品の役割はますます大きくなり、医療現場での利用が拡販されることが期待されます。羊膜に含まれる成分の生理的な特性を理解し、それを応用することは、さらなる治療法の可能性を広げる鍵となります。羊膜製品には、今後も多くの研究が期待され、医療の未来に貢献することが望まれます。 |
